Sarilumab for Patients With Moderate COVID-19 Disease
Clinical trial NCT04359901 · COMPLETED
Trial details
- NCT number
- NCT04359901
- Sponsor
- Westyn Branch-Elliman
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2020-04-10
- Primary completion
- 2021-08-02
- Enrollment
- 50
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.